116 related articles for article (PubMed ID: 16523950)
1. [Fabry disease: Pathogenesis, pathophysiology, and therapy].
Utsumi K
Nihon Rinsho; 2006 Feb; 64 Suppl 2():537-40. PubMed ID: 16523950
[No Abstract] [Full Text] [Related]
2. [Fabry disease (cardiac lysosomal storage disease) associated with heart failure].
Takenaka T; Tei C
Nihon Rinsho; 2007 May; 65 Suppl 5():460-4. PubMed ID: 17571419
[No Abstract] [Full Text] [Related]
3. [Recent therapeutics for Fabry disease].
Etou Y
Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):875-82. PubMed ID: 19469078
[No Abstract] [Full Text] [Related]
4. [Fabry disease].
Jakubowska E; Ryba M; Hruby Z
Przegl Lek; 2006; 63(4):218-9. PubMed ID: 17080745
[TBL] [Abstract][Full Text] [Related]
5. [Fabry disease: new clinical research--current therapeutic perspectives].
Beck M
Wien Klin Wochenschr; 2003 Apr; 115(7-8):215-7. PubMed ID: 12778772
[No Abstract] [Full Text] [Related]
6. Nephropathy in Fabry disease: the importance of early diagnosis and testing in high-risk populations.
Oqvist B; Brenner BM; Oliveira JP; Ortiz A; Schaefer R; Svarstad E; Wanner C; Zhang K; Warnock DG
Nephrol Dial Transplant; 2009 Jun; 24(6):1736-43. PubMed ID: 19293136
[No Abstract] [Full Text] [Related]
7. Anderson-Fabry disease in Austria.
Lorenz M; Hauser AC; Püspök-Schwarz M; Kotanko P; Arias I; Zodl H; Kramar R; Paschke E; Voigtländer T; Sunder-Plassmann G
Wien Klin Wochenschr; 2003 Apr; 115(7-8):235-40. PubMed ID: 12778775
[TBL] [Abstract][Full Text] [Related]
8. [Fabry disease - complex clinical picture, simple diagnosis procedure, causal treatment].
Hoffmann B; Beck M; Rolfs A; Neumann HP
Dtsch Med Wochenschr; 2008 Sep; 133(39):1965-72; quiz 1973-4. PubMed ID: 18798134
[No Abstract] [Full Text] [Related]
9. Uneventful pregnancy outcome after enzyme replacement therapy with agalsidase beta in a heterozygous female with Fabry disease: A case report.
Germain DP; Bruneval P; Tran TC; Balouet P; Richalet B; Benistan K
Eur J Med Genet; 2010; 53(2):111-2. PubMed ID: 20045092
[TBL] [Abstract][Full Text] [Related]
10. The Changing Landscape of Fabry Disease.
Svarstad E; Marti HP
Clin J Am Soc Nephrol; 2020 Apr; 15(4):569-576. PubMed ID: 32132142
[No Abstract] [Full Text] [Related]
11. [Anderson-Fabry's disease: diagnostic problems, therapeutic relevance, and clinical experience in the treatment of the disease with enzyme replacement therapy in nephropathic patients].
Cianciaruso B; Pisani A; Andreucci MV; Parente N; Andria G; Federico S; Sabbatini M; Sessa A
G Ital Nefrol; 2003; 20(2):113-9. PubMed ID: 12746795
[TBL] [Abstract][Full Text] [Related]
12. Fabry nephropathy and the case for adjunctive renal therapy.
Wanner C; Breunig F
J Am Soc Nephrol; 2007 Sep; 18(9):2426-8. PubMed ID: 17699807
[No Abstract] [Full Text] [Related]
13. Fabry disease.
Tarabuso AL
Skinmed; 2011; 9(3):173-7. PubMed ID: 21675497
[TBL] [Abstract][Full Text] [Related]
14. Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: a pilot study.
Mignani R; Panichi V; Giudicissi A; Taccola D; Boscaro F; Feletti C; Moneti G; Cagnoli L
Kidney Int; 2004 Apr; 65(4):1381-5. PubMed ID: 15086478
[TBL] [Abstract][Full Text] [Related]
15. [Neurological manifestations of Fabry disease].
Mendióroz M; Fernández-Cadenas I; Montaner J
Rev Neurol; 2006 Dec 16-31; 43(12):739-45. PubMed ID: 17160925
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic challenges and new therapies for rare lysosomal storage diseases.
Hesselgrave B
Case Manager; 2003; 14(6):48-52. PubMed ID: 14618149
[No Abstract] [Full Text] [Related]
17. Current aspects of Fabry's disease.
Torregrosa JV
Med Clin (Barc); 2018 Sep; 151(5):196-197. PubMed ID: 29523338
[No Abstract] [Full Text] [Related]
18. Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults.
Ortiz A; Oliveira JP; Wanner C; Brenner BM; Waldek S; Warnock DG
Nat Clin Pract Nephrol; 2008 Jun; 4(6):327-36. PubMed ID: 18431378
[TBL] [Abstract][Full Text] [Related]
19. Antiproteinuric therapy and fabry nephropathy: sustained reduction of proteinuria in patients receiving enzyme replacement therapy with agalsidase-beta.
Tahir H; Jackson LL; Warnock DG
J Am Soc Nephrol; 2007 Sep; 18(9):2609-17. PubMed ID: 17656478
[TBL] [Abstract][Full Text] [Related]
20. Fabry disease: treatment and diagnosis.
Rozenfeld PA
IUBMB Life; 2009 Nov; 61(11):1043-50. PubMed ID: 19859978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
